Literature DB >> 11791722

Glycoproteins secreted from suspension-cultured tobacco BY2 cells have distinct glycan structures from intracellular glycoproteins.

R Misaki1, Y Kimura, K Fujiyama, T Seki.   

Abstract

Glycan structures of glycoproteins secreted in the spent medium of tobacco BY2 suspension-cultured cells were analyzed. The N-glycans were liberated by hydrazinolysis and the resulting oligosaccharides were labeled with 2-aminopyridine. The pyridylaminated (PA) glycans were purified by reversed-phase and size-fractionation HPLC. The structures of the PA sugar chains were identified by a combination of the two-dimensional PA sugar chain mapping, MS analysis, and exoglycosidase digestion. The ratio (40:60) of the amount of glycans with high-mannose-type structure to that with plant-complex-type structure of extracellular glycoproteins is significantly different from that (ratio 10:90) previously found in intracellular glycoproteins [Palacpac et al., Biosci. Biotechnol. Biochem. 63 (1999) 35-39]. Extracellular glycoproteins have six distinct N-glycans (marked by *) from intracellular glycoproteins, and the high-mannose-type structures account for nearly 40% (Man5GlcNAc2, 28.8%; Man6GlcNAc2*, 6.4%; and Man7GlcNAc2*, 3.8%), while the plant-complex-type structures account for nearly 60% (GlcNAc2Man3Xyl1GlcNAc2*, 32.1%; GlcNAc1Man3Xyl1GlcNAc2 (containing two isomers)*, 6.2%; GlcNAc2Man3GlcNAc2*, 4.9%; Man3Xyl1Fuc1GlcNAc2, 8.3%; and Man3Xyl1GlcNAc2, 3.7%).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11791722     DOI: 10.1271/bbb.65.2482

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  8 in total

1.  N-Glycosylation of an IgG antibody secreted by Nicotiana tabacum BY-2 cells can be modulated through co-expression of human β-1,4-galactosyltransferase.

Authors:  Catherine Navarre; Nicolas Smargiasso; Laurent Duvivier; Joseph Nader; Johann Far; Edwin De Pauw; Marc Boutry
Journal:  Transgenic Res       Date:  2017-03-22       Impact factor: 2.788

2.  Production of different glycosylation variants of the tumour-targeting mAb H10 in Nicotiana benthamiana: influence on expression yield and antibody degradation.

Authors:  Raffaele Lombardi; Marcello Donini; Maria Elena Villani; Patrizia Brunetti; Kazuhito Fujiyama; Hiroyuki Kajiura; Matthew Paul; Julian K-C Ma; Eugenio Benvenuto
Journal:  Transgenic Res       Date:  2012-01-12       Impact factor: 2.788

3.  Analysis of N-glycan profile of Arabidopsis alg3 cell culture.

Authors:  Ratna Sariyatun; Hiroyuki Kajiura; Juthamard Limkul; Ryo Misaki; Kazuhito Fujiyama
Journal:  Plant Biotechnol (Tokyo)       Date:  2021-12-25       Impact factor: 1.133

4.  N-glycosylation and N-glycan moieties of CTB expressed in rice seeds.

Authors:  Hiroyuki Kajiura; Masashi Wasai; Saori Kasahara; Fumio Takaiwa; Kazuhito Fujiyama
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

5.  The secreted plant N-glycoproteome and associated secretory pathways.

Authors:  Eliel Ruiz-May; Sang-Jin Kim; Federica Brandizzi; Jocelyn K C Rose
Journal:  Front Plant Sci       Date:  2012-06-06       Impact factor: 5.753

6.  The production of human glucocerebrosidase in glyco-engineered Nicotiana benthamiana plants.

Authors:  Juthamard Limkul; Sayoko Iizuka; Yohei Sato; Ryo Misaki; Takao Ohashi; Toya Ohashi; Kazuhito Fujiyama
Journal:  Plant Biotechnol J       Date:  2016-02-12       Impact factor: 9.803

7.  Inactivation of the β(1,2)-xylosyltransferase and the α(1,3)-fucosyltransferase genes in Nicotiana tabacum BY-2 Cells by a Multiplex CRISPR/Cas9 Strategy Results in Glycoproteins without Plant-Specific Glycans.

Authors:  Sébastien Mercx; Nicolas Smargiasso; François Chaumont; Edwin De Pauw; Marc Boutry; Catherine Navarre
Journal:  Front Plant Sci       Date:  2017-03-27       Impact factor: 5.753

8.  Development of patatin knockdown potato tubers using RNA interference (RNAi) technology, for the production of human-therapeutic glycoproteins.

Authors:  Yoon-Sik Kim; Yong-Hwa Lee; Hyun-Soon Kim; Mi-Sun Kim; Kyu-Woong Hahn; Jeong-Heon Ko; Hyouk Joung; Jae-Heung Jeon
Journal:  BMC Biotechnol       Date:  2008-04-03       Impact factor: 2.563

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.